George Gunn

He was division head of Novartis Animal Health until it was sold to Eli Lilly in January 2015. Prior to joining Novartis in 2003 he was president of U.S. Pharmacia Animal Health for three years and held executive roles at Johnson & Johnson for 15 years as well as nine years as a veterinary surgeon.

  • 2015 Annual Report

Added to: Philbro Animal Health Corp. - Teaneck, NJ

Phibro develops a broad range of animal health and mineral nutrition products. Revenues are $972 million.